ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

April 4, 2008

In Brief: Boutwell Declines Nomination to New NCAB Term; Rowley Again Urges Appointment Of Scientists

January 20, 1984

ACS To Accept Database On Method Of Unconventional Rx

November 26, 1993

ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies

June 30, 2006

NIH Changes SBIR/STTG Application Receipt Dates.

February 18, 2000

Three Nutrition RFPs withdrawn Due To “Vagueness”

July 8, 1977